EMTRIVA

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug EMTRIVA contains one active pharmaceutical ingredient (API):

1 Emtricitabine UNII G70B4ETF4S - EMTRICITABINE

Emtricitabine is a synthetic nucleoside analogue of cytidine with activity that is specific to HIV-1, HIV-2 and HBV. Emtricitabine is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate, which competitively inhibits HIV-1 reverse transcriptase, resulting in DNA chain termination. Emtricitabine is a weak inhibitor of mammalian DNA polymerase α, β and ε and mitochondrial DNA polymerase γ. Read about Emtricitabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EMTRIVA Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC
EMTRIVA Oral solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AF09	Emtricitabine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1199976, 1199987
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 03261001, 03261003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 016973
Country: FR	Base de données publique des médicaments	Identifier(s): 61294762, 66717579
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 53797, 91819
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250028M1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1027987, 1027988, 1027989
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 494M2004
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 74292
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11353
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100127619, 100127625
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51483001, W64753001, W64753002
Country: US	FDA, National Drug Code	Identifier(s): 61958-0601, 61958-0602, 70518-1847